I-Mab to Participate at the Piper Sandler Healthcare Conference
ROCKVILLE, Md., Nov. 21, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB, the "Company"), a U.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024.
Piper Sandler 36th Annual Healthcare Conference Presentation Details
|
Presentation Time |
Wednesday, December 4 at 4:30 p.m. ET |
|
Presenters |
Sean Fu, PhD, MBA, Chief Executive Officer Phillip Dennis, MD, PhD, Chief Medical Officer |
|
Webcast link |
|
|
Meetings |
One-on-one and small group meetings: December 3 – 4, 2024 |
|
Management |
Sean Fu, PhD, MBA, Chief Executive Officer Joseph Skelton, Chief Financial Officer Phillip Dennis, MD, PhD, Chief Medical Officer Tyler Ehler, Senior Director, Investor Relations |
The webcast will also be available under "Event Calendar" on I-Mab's IR website
at https://ir.i-mabbiopharma.com/
For more information, please contact your Piper Sandler representative.
What the stars mean:
★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional
Tag:
Related Contents
Latest News
More News
- ViewSonic Reveals Winners of the 5th ColorPro Awards: Celebrating Momentum in Visual Arts (November 22, 2024 | 02:00)
- KIWI design Black Friday & Cyber Monday: 50% OFF Meta Quest 3/3S Accessories! (November 22, 2024 | 01:00)
- ACEFIT PRO: Night Safety Meets Transparent Listening Experience (November 22, 2024 | 01:00)
Mobile Version